Latest News From SMC

11.2.2023

Genomenon Takes a Leap in the Race to Curate the Genome

Genomenon Inc., a leading genomic intelligence company, today announced the first milestone in its journey to curate the human genome with the release of Mastermind 3.0, now including the clinical exome fully curated at the gene level.

Read Article

9.27.2023

ShowdMe raises Series A Financing led by Spring Mountain Capital and Blue Heron Capital

ShowdMe, the premier compliance training partner for home care agencies and skilled nursing facilities, announces today a Series A investment led by Spring Mountain Capital and Blue Heron Capital.

Read Article

7.11.2023

Genomenon Acquires Boston Genetics for Rapid Human Genome Curation

Genomenon Acquires Boston Genetics for Rapid Human Genome Curation.

Read Article

11.14.2022

Maven Announces $90 Million Series E Financing led by General Catalyst.

Maven Announces $90 Million Series E Financing led by General Catalyst.

Read Article

11.11.2022

Recess raises $5 million in Series A funding led by Spring Mountain Capital and Data Point Capital.

Recess raises $5 million in Series A funding led by Spring Mountain Capital and Data Point Capital.

Read Article

10.4.2022

Vergent Bioscience Secures $21.5 Million Series B Financing

Vergent Bioscience, a clinical-stage biotechnology company developing tumor-targeted imaging agents, today announced the close of a $21.5 million Series B financing.

Read Article

7.21.2022

Keen raises $11 million in Series B funding led by Ballast Point Ventures

Keen Decision Systems (“Keen”) announced today that it has closed an $11 million Series B financing led by Ballast Point Ventures IV (“BPV”) to accelerate the industry’s first and only decision optimization engine rooted in predictive analytics

Read Article

4.26.2022

Thentia raises $10 million Series B1 Financing led by Spring Mountain Capital and BDC Capital

The Canadian firm, which helps streamline occupational licenses, has raised $10 million in fresh capital. It also plans to set up a regional HQ in Oklahoma after winning a big state technology contract there.

Read Article

3.10.2022

Genomenon raises $20 million Series B Financing led by Spring Mountain Capital and Beringea

Financing led by Beringea and Spring Mountain Capital to fuel continued growth in pharmaceutical and clinical diagnostic markets

Read Article

3.2.2022

Everwash raises $6 million Series B Financing led by Spring Mountain Capital

EverWash, the US leader in car wash membership and subscription management, today announced they have closed on a $6M Series B investment from Spring Mountain Capital.

Read Article

2.16.2022

Eyrus raises $12 million Series A Financing led by Spring Mountain Capital and Autodesk

It’s going to be a big year for Eyrus. We’re happy to announce that we’ve received $12 million in Series A funding. This means the door is wide open for even bigger opportunities in the near future!

Read Article

2.7.2022

Koneksa raises $45 million in Series C funding led by Matrix Capital Management

Koneksa, the leader in designing and validating digital biomarkers to accelerate drug development, announced today the completion of a $45M Series C financing round, led by AyurMaya, an affiliated fund of Matrix Capital Management, with participation from Takeda Ventures and Velosity Capital.

Read Article

11.11.2021

Spring Mountain Capital completes successful sale of OpenSlate to DoubleVerify for $150 million

Combination will create industry-leading solution for social video and CTV advertisers, marrying OpenSlate’s pre-activation brand suitability and contextual solutions with DV’s established post-bid media quality measurement solutions.

Read Article

10.12.2021

Aware raises $60 million in Series C funding led by Goldman Sachs

Aware, the leading enterprise-grade, collaboration governance platform making sense of human behavioral data, today announced that it has raised a $60 million Series C round

Read Article

10.7.2021

IsoPlexis announces Pricing of Initial Public Offering

IsoPlexis Corporation ("IsoPlexis"), a leader in functional single-cell proteomics, today announced the pricing of its initial public offering of 8,333,000 shares of common stock at a public offering price of $15.00 per share.

Read Article

9.21.2021

Thentia Cloud becomes state-supported software provider for occupational licensing in Oklahoma

Before Oklahoma regulators were introduced to Thentia Cloud in 2019, several agencies found themselves burdened by clunky, outdated licensee databases and processes that ate up budgets and delayed license applications and renewals by weeks – sometimes months – at a time.

Read Article

8.17.2021

Maven raises $110 million in Series D funding co-led by Dragoneer and Lux Capital at a $1 billion valuation

Maven Clinic, the largest virtual clinic for women's and family health, today announced the close of its $110 million Series D funding round, co-led by Dragoneer Investment Group and Lux Capital, with participation from BOND and existing investors Sequoia, Oak HC/FT, and Icon Ventures.

Read Article

8.2.2021

Spring Mountain Capital completes successful sale of RiskSense to Ivanti

Ivanti, the automation platform that discovers, manages, secures, and services IT assets from cloud to edge, today announced it has acquired RiskSense, a pioneer in risk-based vulnerability management and prioritization, to drive the next evolution of patch management.

Read Article

6.2.2021

Spring Mountain Capital completes successful sale of Home Captain to Volly

Volly, an industry-leading provider of lending and marketing technology platforms and creative marketing services for the mortgage and banking industries, announced today that it has acquired Home Captain, a market-leading technology enabled real estate platform that shepherds homebuyers through the home buying journey.

Read Article

5.4.2021

Thentia raises $10 million Series B Financing led by Spring Mountain Capital

Thentia, a global leader in GovTech Software-as-a-Service (SaaS), announced today it has closed a $10 million Series B investment led by New York City-based Spring Mountain Capital with participation from BDC Capital.

Read Article

3.18.2021

Spring Mountain Capital completes successful sale of 180 Health Partners to Mindoula

Mindoula, a digital health innovator and market leader in the tech-enabled delivery of collaborative care and population health management programs for complex populations, today announced the acquisition of 180 Health Partners, a Nashville, TN based company, with a mission to positively impact the trajectory of substance-exposed lives.

Read Article

2.18.2021

Maven CEO Kate Ryder receives the Disruptive Founder of the Year award from Rock Health, Goldman Sachs, and Fenwick & West.

When Kate started Maven in 2014, we were the only company of our kind. Women’s and family health was considered a niche category. Seven years later, we’re so grateful for this recognition—not only of Kate and her extraordinary leadership, but of our entire category as we work toward our mission of changing the health of the world—one woman, one family at a time.

Read Article

1.8.2021

Spring Mountain Capital completes successful sale of Oncoceutics to Chimerix

Chimerix (NASDAQ:CMRX), a biopharmaceutical company focused on accelerating the development of medicines to treat cancer and other serious diseases, today announced that the Company has acquired Oncoceutics, Inc., a privately-held, clinical-stage biotechnology company developing imipridones, a novel class of compounds.

Read Article

1.7.2021

IsoPlexis raises $135 million in Series D funding led by Perceptive Advisors

IsoPlexis, the leader in single-cell functional proteomics, today announced a $135 million Series D financing comprised of $85 million in equity securities and a $50 million credit facility.

Read Article

12.14.2020

Aware raises $12 million Series B Financing led by Spring Mountain Capital

Aware, the only comprehensive AI solution for governance, risk, compliance (GRC) and insights for leading digital collaboration technologies, is thrilled to share it recently closed a $12 million Series B equity investment.

Read Article

12.9.2020

The Scientist names IsoPlexis single-cell intracellular proteome a Top 10 Innovation of 2020

From a rapid molecular test for COVID-19 to tools that can characterize the antibodies produced in the plasma of patients recovering from the disease, this year’s winners reflect the research community’s shared focus in a challenging year.

Read Article

10.13.2020

Spring Mountain Capital completes successful sale of Doctor.com to Press Ganey

Press Ganey today announced the expansion of its market-leading health care consumerism platform with the acquisitions of Doctor.com and a majority equity stake in Binary Fountain.

Read Article

9.29.2020

Konkesa raises $16 million Series B Financing led by Spring Mountain Capital

Koneksa, the leader in developing and implementing patient-centric digital biomarkers for drug development, announced today the completion of a $16M Series B financing round.

Read Article

2.28.2020

Maven raises $45 million in Series C funding led by Icon Ventures

The leader in women's and family health expands into payments with the launch of Maven Wallet

Read Article